DxS Licenses Technology To DuPont
February 02 2009 - 10:19AM
Dow Jones News
U.K. diagnostics company DxS Ltd. Monday said it has licensed
its Scorpions technology to chemicals giant DuPont Co. (DD).
The license was granted to DuPont Qualicon, a unit of DuPont
that sells systems used by food companies to screen their products
for potentially dangerous bugs. Financial terms weren't
disclosed.
DuPont is the latest big company to strike a deal with
Manchester, England-based DxS. Biotechnology major Amgen Inc.
(AMGN) uses a DxS test to determine whether patients with a certain
genetic mutation are likely to respond to its cancer drug Vectibix,
while Swiss pharmaceutical company Roche Holding AG (ROG.VX) also
has a distribution deal with the firm.
Company Web site: www.dxsdiagnostics.com
-By Jason Douglas, Dow Jones Newswires; 44-20-7842-9272;
jason.douglas@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front
page of today's most important business and market news, analysis
and commentary. You can use this link on the day this article is
published and the following day.